FI972493A0 - Erytromysiini A:n 9-0-oksiimijohdannaisia, joilla on antibioottista aktiivisuutta - Google Patents

Erytromysiini A:n 9-0-oksiimijohdannaisia, joilla on antibioottista aktiivisuutta

Info

Publication number
FI972493A0
FI972493A0 FI972493A FI972493A FI972493A0 FI 972493 A0 FI972493 A0 FI 972493A0 FI 972493 A FI972493 A FI 972493A FI 972493 A FI972493 A FI 972493A FI 972493 A0 FI972493 A0 FI 972493A0
Authority
FI
Finland
Prior art keywords
erythromycin
antibiotic activity
oxime derivatives
oxime
derivatives
Prior art date
Application number
FI972493A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972493L (fi
FI972493A7 (fi
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI972493L publication Critical patent/FI972493L/fi
Publication of FI972493A7 publication Critical patent/FI972493A7/fi
Publication of FI972493A0 publication Critical patent/FI972493A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI972493A 1994-12-13 1995-12-07 Erytromysiini A:n 9-0-oksiimijohdannaisia, joilla on antibioottista aktiivisuutta FI972493A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (3)

Publication Number Publication Date
FI972493L FI972493L (fi) 1997-06-12
FI972493A7 FI972493A7 (fi) 1997-06-12
FI972493A0 true FI972493A0 (fi) 1997-06-12

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972493A FI972493A0 (fi) 1994-12-13 1995-12-07 Erytromysiini A:n 9-0-oksiimijohdannaisia, joilla on antibioottista aktiivisuutta

Country Status (35)

Country Link
US (1) US5847092A (cs)
EP (1) EP0797579B1 (cs)
JP (1) JPH10510520A (cs)
KR (1) KR100367559B1 (cs)
CN (1) CN1046535C (cs)
AP (1) AP739A (cs)
AT (1) ATE190620T1 (cs)
AU (1) AU690791B2 (cs)
BG (1) BG63261B1 (cs)
BR (1) BR9510015A (cs)
CA (1) CA2207029A1 (cs)
CZ (1) CZ289943B6 (cs)
DE (1) DE69515694T2 (cs)
DK (1) DK0797579T3 (cs)
EE (1) EE03401B1 (cs)
ES (1) ES2144154T3 (cs)
FI (1) FI972493A0 (cs)
GE (1) GEP20012391B (cs)
GR (1) GR3033622T3 (cs)
HU (1) HU220631B1 (cs)
IT (1) IT1276901B1 (cs)
LT (1) LT4276B (cs)
LV (1) LV11898B (cs)
MD (1) MD1788G2 (cs)
NO (1) NO309816B1 (cs)
NZ (1) NZ297446A (cs)
OA (1) OA10491A (cs)
PL (1) PL182053B1 (cs)
PT (1) PT797579E (cs)
RO (1) RO116282B1 (cs)
RU (1) RU2152951C1 (cs)
SI (1) SI9520124A (cs)
TJ (1) TJ306B (cs)
UA (1) UA48958C2 (cs)
WO (1) WO1996018633A1 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
RU2186389C1 (ru) * 2001-01-09 2002-07-27 Государственное федеральное учреждение науки Уральский научно-исследовательский институт травматологии и ортопедии Способ культивирования h. influenzae из носоглоточной слизи (варианты)
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
RU2207120C1 (ru) * 2001-12-29 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство брилид антибиотического действия
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
RU2240112C1 (ru) * 2003-06-09 2004-11-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
EP0284203A3 (en) 1987-02-24 1989-11-02 Beecham Group Plc Erythromycin derivatives, process for their preparation and their pharmaceutical use
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives

Also Published As

Publication number Publication date
GR3033622T3 (en) 2000-10-31
AP9700989A0 (en) 1997-07-31
FI972493L (fi) 1997-06-12
FI972493A7 (fi) 1997-06-12
MD970243A (en) 1999-05-31
CZ178697A3 (en) 1997-12-17
ES2144154T3 (es) 2000-06-01
ATE190620T1 (de) 2000-04-15
DE69515694D1 (de) 2000-04-20
EP0797579A1 (en) 1997-10-01
NO972702D0 (no) 1997-06-12
AU690791B2 (en) 1998-04-30
NO972702L (no) 1997-08-13
LT97116A (en) 1997-10-27
NO309816B1 (no) 2001-04-02
CN1169727A (zh) 1998-01-07
MX9704253A (es) 1997-09-30
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
BG101570A (bg) 1998-02-27
UA48958C2 (uk) 2002-09-16
EE03401B1 (et) 2001-04-16
AU4260396A (en) 1996-07-03
ITMI942496A1 (it) 1996-06-13
RO116282B1 (ro) 2000-12-29
HU220631B1 (hu) 2002-03-28
GEP20012391B (en) 2001-03-25
OA10491A (en) 2002-04-10
CN1046535C (zh) 1999-11-17
CZ289943B6 (cs) 2002-04-17
DE69515694T2 (de) 2000-10-26
LV11898B (en) 1998-03-20
LT4276B (lt) 1998-01-26
AP739A (en) 1999-03-24
WO1996018633A1 (en) 1996-06-20
BG63261B1 (bg) 2001-07-31
LV11898A (lv) 1997-12-20
SI9520124A (sl) 1998-04-30
PT797579E (pt) 2000-08-31
DK0797579T3 (da) 2000-06-05
KR100367559B1 (ko) 2003-04-21
EP0797579B1 (en) 2000-03-15
EE9700124A (et) 1997-12-15
HUT77126A (hu) 1998-03-02
PL320688A1 (en) 1997-10-27
JPH10510520A (ja) 1998-10-13
CA2207029A1 (en) 1996-06-20
ITMI942496A0 (it) 1994-12-13
PL182053B1 (pl) 2001-10-31
US5847092A (en) 1998-12-08
NZ297446A (en) 1999-06-29
BR9510015A (pt) 1997-10-28
TJ306B (en) 2001-08-06
RU2152951C1 (ru) 2000-07-20
IT1276901B1 (it) 1997-11-03

Similar Documents

Publication Publication Date Title
FI971397L (fi) Sykliset haksapeptidit, joilla on antibioottinen aktiivisuus
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
LV11547A (lv) Makrolidi ar imunodepresantu aktivitati
NO308361B1 (no) Nye erytromycinderivater, samt legemidler som inneholder slike
FI972493A0 (fi) Erytromysiini A:n 9-0-oksiimijohdannaisia, joilla on antibioottista aktiivisuutta
FI962751L (fi) Uusia hydroksyyliryhmän sisältäviä 1,3-dialkyyliureajohdannaisia
IS5251A (is) 9-oxím erýþrómýsín afleiður
NO910723L (no) Karbapenemderivater med antibiotisk aktivitet, samt fremstilling og anvendelse derav.
ZA9710648B (en) Erythromycin A derivatives.
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
DK1025114T3 (da) 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet
FI960529L (fi) Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents (b,f)oksepiinit
AU9649698A (en) Erythromycin a 11, 12-carbamate derivatives
KR950702182A (ko) 면역억제 활성를 갖는 신규항생물질 데라미노마이신류와 이들의 제조방법
FI892788L (fi) Tumoermotverkande bu-3420t -antibiotikum.
ZA978546B (en) Erythromycin A derivatives.
FI943676A7 (fi) Oksiimijohdannaiset, joilla on kefalosporaanirakenne ja yhdisteet niiden valmistamiseksi
EP0616999A3 (en) 4-Fluorobiphenyl derivatives.
SI0966477T1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
IT8423443V0 (it) Porta basculante, provvista di un dispositivo perfezionato di richiamo elastico.
FI1808U1 (fi) Haollare foer tillbehoer till transporterbara maskiner, saerskilt rengoeringsmaskiner
HK1030782A (en) 6, 9-bridged erythromycin derivatives
HK1031385A (en) 6, 11-bridged erythromycin derivatives
ITMI932069A0 (it) Nuovo antibiotico
ES1030041Y (es) Estuche para cintas de vidrio, perfeccionado.

Legal Events

Date Code Title Description
MA Patent expired